Bone Biologics Corporation (BBLGW)

NASDAQ: BBLGW · Real-Time Price · USD · Warrants
15.00
0.00 (0.00%)
At close: Jun 18, 2025
0.00%
Market Cap 2.28M
Revenue (ttm) n/a
Net Income (ttm) -7.48M
Shares Out 545.17K
EPS (ttm) -20.88
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 276
Open n/a
Previous Close n/a
Day's Range n/a
52-Week Range 3.00 - 95.04
Beta 1.28
Analysts n/a
Price Target n/a
Earnings Date Feb 21, 2025

About BBLGW

Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company’s medical device NELL-1/DBM, an osteopromotive recombinant protein that provides target-specific control over bone regeneration. It also develops NELL-1/DBM fusion device used in lumbar spinal fusion. The company’s NELL-1 platform technology used in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventiona... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2004
Employees 2
Stock Exchange NASDAQ
Ticker Symbol BBLGW
Full Company Profile

News

There is no news available yet.